comparemela.com

Latest Breaking News On - Hepatic cell therapy support - Page 1 : comparemela.com

Catalent opens Belgium cell therapy plant - BioProcess Insider

The 60,000 square-foot dedicated manufacturing facility will support autologous and allogeneic cell therapy projects, says CDMO Catalent.

New jerseyUnited statesWaals gewestAlessandro maselliManja boermanAdelphi geneticsHepatic cell therapy supportRheincell therapeuticsCatalent cellGene therapy

Catalent continues to grow Center of Excellence in Belgium with latest acquisition

Catalent, the Somerset-based provider of drug delivery technologies, is continuing its growth in Europe, acquiring a new facility in Gosselies, Belgium, it announced this week. The company said in a news release that it has acquired Promethera Biosciences’ cell therapy manufacturing subsidiary, Hepatic Cell Therapy Support SA, and its 32,400-square-foot facility, which will be used to accommodate Catalent’s new commercial-scale plasmid DNA manufacturing. The facility, which has an existing clean room and other laboratory and warehouse space, will be reequipped for Catalent’s needs. It is located on Catalent’s existing campus in Gosselies and represents the third acquisition at the location.

Waals gewestPromethera bioscienceManja boermanHepatic cell therapy supportCatalent cellGene therapyகீந் சிகிச்சை

Catalent acquires facility in Belgium for commercial-scale plasmid DNA manufacturing

Privacy Overview This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience. Necessary

Waals gewestManja boermanEtienne sokalHepatic cell therapy supportAdelphi geneticsCatalent cellடெல்பி ஜெநெடிக்ஸ்

Catalent Acquires Additional Facility at its Gosselies, Belgium Campus for Commercial-Scale Plasmid DNA Manufacturing

Catalent Acquires Additional Facility at its Gosselies, Belgium Campus for Commercial-Scale Plasmid DNA Manufacturing Share Article Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Promethera Biosciences, the world leader in advanced therapy development for severe liver diseases, today announced that Catalent has acquired Promethera’s cell therapy manufacturing subsidiary, Hepatic Cell Therapy Support SA (HCTS), including its 32,400 square-foot (3,010 square-meter) facility in Gosselies, Belgium. The facility will accommodate Catalent’s new commercial-scale plasmid DNA (pDNA) manufacturing and will provide the opportunity for the immediate growth of Catalent’s pDNA service offering, which was recently acquired from Delphi Genetics to support the growing cell and gene therapy pipeline.

United statesNew jerseyWaals gewestEtienne sokalPromethera biosciencesManja boermanEuropean centerHepatic cell therapy supportAdelphi geneticsCatalent cellGene therapyஒன்றுபட்டது மாநிலங்களில்புதியது ஜெர்சிஐரோப்பிய மையம்டெல்பி ஜெநெடிக்ஸ்கீந் சிகிச்சை

Catalent (NYSE:CTLT) - Catalent Buys Promethera s Cell Therapy Subsidiary To Scale-Up Plasmid DNA Efforts

Catalent (NYSE:CTLT) - Catalent Buys Promethera s Cell Therapy Subsidiary To Scale-Up Plasmid DNA Efforts
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Waals gewestCatalent incHepatic cell therapy supportAdelphi geneticsடெல்பி ஜெநெடிக்ஸ்

vimarsana © 2020. All Rights Reserved.